Eagle Pharmaceuticals Inc (EGRX)
4.15
-0.09
(-2.12%)
USD |
NASDAQ |
Apr 26, 16:00
4.15
0.00 (0.00%)
After-Hours: 20:00
Eagle Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 73.92% |
| March 31, 2023 | 73.91% |
| December 31, 2022 | 67.27% |
| September 30, 2022 | 64.11% |
| June 30, 2022 | 68.08% |
| March 31, 2022 | 76.05% |
| December 31, 2021 | 70.91% |
| September 30, 2021 | 79.28% |
| June 30, 2021 | 77.65% |
| March 31, 2021 | 73.68% |
| December 31, 2020 | 74.88% |
| September 30, 2020 | 75.99% |
| June 30, 2020 | 68.68% |
| March 31, 2020 | 83.04% |
| December 31, 2019 | 75.98% |
| September 30, 2019 | 63.73% |
| June 30, 2019 | 62.46% |
| March 31, 2019 | 73.69% |
| December 31, 2018 | 66.89% |
| September 30, 2018 | 74.69% |
| June 30, 2018 | 68.70% |
| March 31, 2018 | 74.68% |
| Date | Value |
|---|---|
| December 31, 2017 | 70.70% |
| September 30, 2017 | 81.49% |
| June 30, 2017 | 72.42% |
| March 31, 2017 | 76.57% |
| December 31, 2016 | 76.81% |
| September 30, 2016 | 72.44% |
| June 30, 2016 | 71.96% |
| March 31, 2016 | 50.70% |
| December 31, 2015 | 85.71% |
| September 30, 2015 | 34.57% |
| June 30, 2015 | 44.22% |
| March 31, 2015 | 83.62% |
| December 31, 2014 | 19.84% |
| September 30, 2014 | 22.64% |
| June 30, 2014 | 73.14% |
| March 31, 2014 | 32.87% |
| December 31, 2013 | 15.80% |
| September 30, 2013 | 36.82% |
| June 30, 2013 | 42.36% |
| March 31, 2013 | 47.07% |
| December 31, 2012 | 85.76% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
62.46%
Minimum
Jun 2019
83.04%
Maximum
Mar 2020
72.33%
Average
73.91%
Median
Mar 2023
Gross Profit Margin (Quarterly) Benchmarks
| Inspire Medical Systems Inc | 85.43% |
| Soligenix Inc | -- |
| Marinus Pharmaceuticals Inc | 87.66% |
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |